Delcath Systems, Inc.
Industry
- Medical Devices
- Pharmaceuticals
- Specialty Pharmaceuticals
- Drug Delivery
- Site Specific
- Biotechnology
Latest on Delcath Systems, Inc.
The US Food and Drug Administration closed out last week with the approvals of two novel agents for rare diseases, Travere Therapeutics, Inc. 's Filspari for IgA nephropathy and Chiesi Global Rare Di
Two novel device or indication approvals were added to Medtech Insight 's Approvals Tracker last week. Among them, Tandem Diabetes Care Inc. netted a first with US FDA. On Feb. 14, the agency gra
Delcath Systems Inc. ’s decision to overhaul the ongoing Phase III study for its melphalan chemosaturation system could get the company closer to resubmitting a new drug application in 2019 but also b
The Singapore-based, oncology-focused venture Aslan Pharmaceuticals Pte. Ltd. , which is developing a pipeline of assets for Asia-prevalent tumor types, will float on the Taipei Exchange (TPEx) aft